Cargando…
Pharmacological targeting of natural killer cells for cancer immunotherapy
Natural killer (NK) cells are innate lymphocytes that rapidly respond to cancer cells without prior sensitization or restriction to the cognate antigen in comparison with tumor antigen‐specific T cells. Recent advances in understanding NK‐cell biology have elucidated the molecular mechanisms underly...
Autores principales: | Miyazato, Kiho, Hayakawa, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293096/ https://www.ncbi.nlm.nih.gov/pubmed/32301190 http://dx.doi.org/10.1111/cas.14418 |
Ejemplares similares
-
Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells
por: Miyazato, Kiho, et al.
Publicado: (2020) -
Lung‐resident natural killer cells control pulmonary tumor growth in mice
por: Yamamoto, Yutaka, et al.
Publicado: (2018) -
Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023) -
Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021) -
Natural killer cell immunotherapy in glioblastoma
por: Hosseinalizadeh, Hamed, et al.
Publicado: (2022)